Patents by Inventor Eric CHETAILLE

Eric CHETAILLE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT
    Publication number: 20240122915
    Abstract: The present invention concerns a combination comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and a PD-1 and/or PD-L1 inhibitor, for use as a medicament. It also concerns a pharmaceutical composition comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and PD-1 and/or PD-L1 inhibitor.
    Type: Application
    Filed: May 11, 2023
    Publication date: April 18, 2024
    Applicant: ACTIVE BIOTECH AB
    Inventors: Jose Amauri SOARES, Eric CHETAILLE, Jessica NAKHLE, Fabien SCHMIDLIN
  • COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT
    Publication number: 20200129499
    Abstract: The present invention concerns a combination comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and a PD-1 and/or PD-L1 inhibitor, for use as a medicament. It also concerns a pharmaceutical composition comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and PD-1 and/or PD-L1 inhibitor.
    Type: Application
    Filed: December 17, 2019
    Publication date: April 30, 2020
    Applicant: ACTIVE BIOTECH AB
    Inventors: Jose Amauri SOARES, Eric CHETAILLE, Jessica NAKHLE, Fabien SCHMIDLIN
  • COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT
    Publication number: 20180050030
    Abstract: The present invention concerns a combination comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and a PD-1 and/or PD-L1 inhibitor, for use as a medicament. It also concerns a pharmaceutical composition comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and PD-1 and/or PD-L1 inhibitor.
    Type: Application
    Filed: February 16, 2016
    Publication date: February 22, 2018
    Inventors: José Amauri SOARES, Eric CHETAILLE, Jessica NAKHLE, Fabien SCHMIDLIN